89 related articles for article (PubMed ID: 958587)
21. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
Frattola L; Albizzati MG; Spano PF; Trabucchi M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
[No Abstract] [Full Text] [Related]
22. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
23. Dopamine agonists in the treatment of Parkinson's disease.
Rinne UK
Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
[TBL] [Abstract][Full Text] [Related]
24. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
25. Role of ergot derivatives in the treatment of parkinsonism.
Calne DB
Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459
[No Abstract] [Full Text] [Related]
26. [Considerations in the drug treatment of parkinsonism (author's transl)].
Hungerbühler JP; Regli F
Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976
[No Abstract] [Full Text] [Related]
27. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
28. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
29. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
30. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; Martínez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
31. Newer therapies for Parkinson's disease.
Korczyn AD; Nisipeanu P
Neurol Neurochir Pol; 1996; 30 Suppl 2():105-11. PubMed ID: 9100248
[No Abstract] [Full Text] [Related]
32. Bromocriptine--a versatile remedy.
Joffe BI; Distiller LA; Seftel HC
S Afr Med J; 1977 Jun; 51(26):954-5. PubMed ID: 578015
[No Abstract] [Full Text] [Related]
33. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Klawans HL; Paleologos N
Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
[TBL] [Abstract][Full Text] [Related]
34. Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Baas H; Schneider E; Fischer PA; Japp G
J Neural Transm; 1985; 64(1):45-54. PubMed ID: 4067602
[TBL] [Abstract][Full Text] [Related]
35. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
36. Pergolide versus bromocriptine.
Login IS
Neurology; 1984 Feb; 34(2):258. PubMed ID: 6538025
[No Abstract] [Full Text] [Related]
37. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
38. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
39. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Hutt CS; Snider SR; Fahn S
Neurology; 1977 Jun; 27(6):503-10. PubMed ID: 577299
[TBL] [Abstract][Full Text] [Related]
40. Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Aug; 26(8):741-3. PubMed ID: 181692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]